GSE191181
Evaluation of chromatin accessibility during prostate cancer progression
We performed ATAC-seq analyses of freshly dissociated epithelial tumor cells at the early stage (W2) or the late stage (M6) of NEPC progression. Overall design: Chromatin accessibility of prostate tumor cells at the early stage (W2) or the late stage (M6) of NEPC progression.